Preparation of a cyclic RGD: Modified liposomal SiRNA formulation for use in active targeting to Tumor and Tumor endothelial cells

Yu Sakurai, Tomoya Hada, Hideyoshi Harashima

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

The delivery of SiRNA is not only a challenging strategy for developing new remedies, but is also useful as an analytic tool for an in vivo phenotypic alteration by loss-of-function. Specifically, ligand-mediated SiRNA active targeting can be used to silence any gene in any organ of interest. In this chapter, we describe the preparation of an active targeting system to tumor endothelial cells (TECs) using liposomal SiRNA modified with cyclic RGD peptides. The procedure consists of essentially three steps: (1) the synthesis of a cyclic RGD peptide derivative, (2) SiRNA encapsulation into a liposomal delivery system, and (3) modification of liposomal SiRNA with a cyclic RGD derivative.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
DOIs
Publication statusPublished - 2016
Externally publishedYes

Publication series

NameMethods in Molecular Biology
Volume1364
ISSN (Print)1064-3745

Keywords

  • Active targeting
  • Liposomal delivery system
  • SiRNA
  • Tumor
  • Tumor endothelial cells

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Preparation of a cyclic RGD: Modified liposomal SiRNA formulation for use in active targeting to Tumor and Tumor endothelial cells'. Together they form a unique fingerprint.

Cite this